Tézisekhez kapcsolódó idézhető idegen nyelvű absztraktok

R. Shaoul, D. Turner, M. Sladek, G. Veres, G. Veerman-Wauters, J. Escher, A. Paerregaard, J. Amil Dias, P. Lionetti, A. Levine. Limitations of fecal calprotectin at diagnosis in untreated pediatric Crohn's Disease. JCC, 2012;06:S48.

Levine, M. Sladek, R. Shaoul, G. Veres, J. Amil Dias, J. Escher, D. Turner. Exclusive enteral nutrition is superior to corticosteroids and mesalamine for achieving remission with normalization of CRP in new onset pediatric Crohn's Disease. JCC, 2012;06:S111.

B.D. Lovasz, L. Lakatos, A. Horvath, T. Pandur, Z. Erdelyi, G. Mester, M. Balogh, I. Szipocs, C. Molnar, E. Komaromi, G. Veres, P.A. Golovics, L.S. Kiss, P. Lakatos. Incidence rates and disease course of pediatric IBD in Western Hungary between 1977-2008. JCC, 2012;06:S173.

G. Veres, HUPIR, M. Papp, P. Lakatos. A nation-wide registry of pediatric IBD:

epidemiology, activity indices, laboratory data, therapeutic managements, and one year follow-up. JCC 2012;06:S179.

P. Bontems, N. Kalach, B. Iwanczak, T. Casswall, S. Koletzko, G. Oderda, M. Martinez-Gomez, P. Urruzuno, A. Kindermann, J. Sykora, G. Veres, E. Roma, E. Pehlivanoglu, F.

Megraud, S. Cadranel. Prospective European multicentre epidemiologic case-control study on risk factors of gastric and duodenal ulcers or erosions in children. ESPGHAN, JPGN,,2011,52, Suppl.2, E25

G. Veres, E. Kővári, D. Szabó, K. Molnár, A. Dezsőfi, M. Papp, P. L. Lakatos, Á. Cseh, A.

Arató. Improvement in biomarkers of bone formation during 54-week infliximab therapy in pediatric patients with Crohn’s disease. ESPGHAN, JPGN,2011,52, Suppl.2, E44

K. Molnár, Á. Vannay, B. Szebeni, E. Sziksz, N. F. Bánki, Á. Cseh, A. Dezsőfi, P. L.

Lakatos, H. Győrffy, D. Nagy Szakáll, M. Papp, A. Arató, T. Tulassay, G. Veres. Intestinal alkaline phosphatase in mucosa of pediatric patients with inflammatory bowel disease.

ESPGHAN, JPGN,2011,52, Suppl.2, E152

M. Kovács, É. Nemes, M. Polgár, E. Sólyom, Á Horváth, P. Bódi, S. Jacobsen, K. Molnár, K.

E. Müller, Á Cseh, A. Dezsőfi, A. Arató, G. Veres. Antibodies against Saccharomyces cerevisiae are associated with penetrating disease behavior and perianal disease, but

pancreatic autoantibodies are not related to clinical presentation, medical therapy, and need for surgery in pediatric-onset IBD. ESPGHAN, JPGN,2011,52, Suppl.2, E153

Várkonyi I, Nyitrai A, Veres G, Kis É. How much better is small intestine contrast sonography (SICUS) than sonography in diagnosing inflammatory bowel disease in children?

Pediatr Radiol,,2011;41 Suppl:261

Papp M, Koromi Z, Davida L, Altorjay I, Palatka K, Udvardy M, Norman GL, Shums Z, Veres G, Kiss SL, Lakatos PL, Harsfalvi J. Formation of antiphospholipid antibodies (APLA) is associated to the presence of anti-Saccharomyces cerevisiae antibodies (ASCA) in inflammatory bowel disease. JCC, 2011, 5: S165.

Molnár K, Cseh Á, Nagy Szakáll D, Szalay B, Lakatos P, Arató A, Tulassay T, Dezsőfi A, Veres G. Characteristics of innate and adaptive immunity in the peripherial blood of pediatric patients with Crohn disease after infliximab treatment. Annual meeting of ESPGHAN, JPGN,2010,Suppl, PA-DG-045,p:121.

Nagy Szakáll D, Papp M, Körner A, Pályu E, Molnár K, Dezsőfi A, Arató A, Veres G.

Haptoglobin polymorphism in children with type 1 diabetes mellitus and with diabetes and celiac disease. Annual meeting of ESPGHAN, JPGN, 2010, Suppl, PO-G-164,p:150.

Kovács M, HUPIR, Veres G. What is the real significance of upper gastrointestinal endoscopy in pediatric patients with inflammatory bowel disease (IBD)? Annual meeting of ESPGHAN, JPGN, 2010, Suppl, PO-G-234,p:167 .

Müller KE, HUPIR, Veres G. Correlation of IBD activity indexes and extraintestinal manifestation of 264 newly diagnosed patients with IBD. Annual meeting of ESPGHAN, JPGN, 2010, Suppl, PO-G-237,p:168.

Veres G, Szabó D, Müller KE, Molnár K, Dezsőfi A, Arató A. Infliximab treatment and quality of life in pediatric patients with Crohn disease using validated questionnaire (IMPACT-III). Annual meeting of ESPGHAN, JPGN, 2010, Suppl,PO-G-257,p:173.

Veres G, HUPIR Study Group, Papp M, Lakatos P. Prevalence of extraintestinal manifestation in inflammatory bowel disease according th the Hungarian Pediatric IBD Rergistry (HUPIR). JCC, 2010;1(4):S107.

Szebeni B, Sziksz E, Vannay Á, Veres G, Dezsőfi A, Ónódy A, Korponay-SZ.I, Szabó A, Tulassay T, Arató A. Increased heat shock protein 72 expression in celiac children. J Pediatr Gastroenterol Nutr,,2009; 48(Suppl 3): PG1-02.

Sziksz E, Szebeni B, Vannay Á, Veres G, Dezsőfi A, Ónódy A, Korponay-SZ.I, Szabó A, Tulassay T, Arató A. Hypoxia inducible factor 1 alpha expression in celiac disease. J Pediatr Gastroenterol Nutr, 2009; 48(Suppl 3): PG1-14.

Veres G, Papp M, Lakatos PL, Hungarian IBD Registry Group (HUPIR). First 2-year analysis of prospectively diagnosed patients with IBD in the Hungarian IBD Registry (HUPIR). J Pediatr Gastroenterol Nutr,2009; 48(Suppl 3): PG2-22.

Cseh Á, Szebeni B, Szalay B, Vásárhelyi B, Arató A, Veres G. Hematochezia: allergic bowel inflammation in infants? J Pediatr Gastroenterol Nutr, 2009; 48(Suppl 3): PG5-07.

Escher JC, on behalf of the IBD working group of ESPGHAN. Diagnostic work-up of IBD patients in Europe: results of a 5-year audit of EUROKIDS. J Pediatr Gastroenterol Nutr, 2009; 48(Suppl 3):E2 (OP1-03).

Veres G, Pintér P, Molnár K, Győrffy H, Dezsőfi A, Arató A. Laboratory and colonoscopic characteristics of infants with eosinophilic/allergic colitis. Z Gastroenterol, 2009;44,215.

Veres G, Papp M, Lakatos P, and Hungarian Pediatric IBD Registry Group. Characteristics of patients prospectively recruited in the Hungarian Pediatric IBD Registry (HUPIR). JCC, 2009;3:S110-111.

Veres G, Hungarian Pediatric IBD Registry Group. First year (2007) analysis of the Hungarian pediatric inflammatory bowel disease registry (HUPIR). Z Gastroenterol, 2008;44,420.

Kalach N, Bontems P, Koletzko S, Mourad-Baars P, Shcherbakov P, Celinska-Cedro D, Iwanczak B, Gottrand F, Martinez-Gomez MJ, Pehlivanoglu E, Oderda G, Urruzuno P, Casswall T, Lamireau T, Sykora J, Roma-Giannikou E, Veres G, Wewer V, Charkaluk ML, Mégraud F, Cadranel S. Prospective European multi-centre pilot study on gastric and duodenal ulcer disease or erosions in children. Acta Gastroenrol Belg, 2008;71:D09.

Kalach N, Bontems P, Mourad-Baars P, Koletzko S, Scherbakov P, Celinska-Cedro D, Iwanczak B, Gottrand F, Martinez Gomez M, Pehlivanoglu E, Oderda G, Urruzunu P, Casswall T, Lamireau T, Sykora J, Roma E, Veres G, Wewer V, Charlakuk M, Megraud F, Cadranel S. Prospective European multicenter pilot study on gastric and duodenal ulcer disease or erosions in children. Helicobacter,2007;4:394.

Veres G, Papp M, Lakatos PL, Arato A, Molnár K, Tornai I, Dezsőfi A, Szőnyi L.

Haptoglobin polymorphism in primary sclerosing cholangitis. J Ped Gastro Nutr, 2007;44, suppl, 28.

Szebeni B, Veres G, Dezsőfi A, Vannay Á, Vásárhelyi B, Korponay-Szabó Ilma, Arató A.

Mucosal expression of Toll-like receptor (TLR) 2 and TLR4 in treated coeliac disease. Z Gastroenterol, 2007, 44, 446.

Veres G, Győrffy H, Nagy Szakáll D, Szabó E, Dezsőfi A, Molnár K, Szőnyi L, Bodánszky H, Arató A. Claudins expression in the proximal and distal parts of duodenum in patients with celiac disease. Z Gastroenterol 2007, 44, 450.

Veres G, Szebeni B, Marz M, Dezsőfi A, Vannay A, Vasarhelyi B, Majorova E, Arato A.

Expression of mRNA and protein of Toll-like receptors 2 and 4 are upregulated in children with IBD. J. Pediatr Gastroenterol Nutr, 2006,43, suppl2, S14.

Szebeni B, Mraz M, Veres G, Dezsőfi A, Vannay A, Vásárhelyi B, Majorova E, Arató A.

Increased expression of toll-like receptor (TLR)2 and TLR4 in the colonic mucosa of children with active inflammatory bowel disease. J. Pediatr Gastroenterol Nutr, 2006, 42(5):E29.

Szebeni B, Mraz M, Veres G, Dezsőfi A, Vannay Á, Vásárhelyi B, Majorova E, Arató A.

Toll-like receptors TLR2, TLR3 and TLR4 expression in active IBD. Z Gastroenterol, 2006, 41, 446.

Veres G, Maka E, Domsa P, Glasz T, Szabó T, Szőnyi L, Dezsőfi A, Bodánszky H, Vojnisek Zs, Kovács L, Farkas V, Arató A. New form of antral and duodenal ulcer in children:

plasminogen deficiency. Z Gastroenterol, 2006, 43, 454.

Szebeni B, Veres G, Dezsőfi A, Vannay Á, Rusai K, Szőnyi L, Vásárhelyi B, Arató A.

Increased Toll like receptor (TLR2 and TLR4) expression in the small intestinal mucosa of children with coeliac disease. J Pediatr Gastroenterol Nutr, 2005, 40,633.

Szebeni B, Veres G, Dezsőfi A, Vannay Á, Rusai K, Szőnyi L, Vásárhelyi B, Arató A.

Mucosal expression of Toll-like receptors (TLR2 and TLR4) in children with celiac disease. Z Gastroenterol, 2005;43:514.